Cabozantinib: targeted therapy back to the future?
Ann Oncol
.
2017 Mar 1;28(3):450-451.
doi: 10.1093/annonc/mdx015.
Author
G Abou-Alfa
1
2
Affiliations
1
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
2
Department of Medicine, Weill Cornell Medical College, New York, USA.
PMID:
28137742
DOI:
10.1093/annonc/mdx015
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anilides*
Humans
Pyridines*
Substances
Anilides
Pyridines
cabozantinib